<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0037315" disease_type="Disease or Syndrome" abbrv="">Sleep-disordered breathing</z:e> (SDB) has been associated with <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and <z:hpo ids='HP_0000833'>glucose intolerance</z:hpo>, and is frequently found in people with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>SDB not only causes poor sleep quality and daytime sleepiness, but has clinical consequences, including <z:hpo ids='HP_0000822'>hypertension</z:hpo> and increased risk of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>In addition to supporting the need for further research into the links between SDB and <z:mp ids='MP_0002055'>diabetes</z:mp>, the International <z:mp ids='MP_0002055'>Diabetes</z:mp> Federation Taskforce on Epidemiology and Prevention strongly recommends that health professionals working in both type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and SDB adopt clinical practices to ensure that a patient presenting with one condition is considered for the other </plain></SENT>
</text></document>